Username Password
PINA
New dengue vaccine approved for use in French Polynesia
3:13 pm GMT+12, 20/12/2018, French Polynesia

 The first vaccine against dengue can go on sale in French Polynesia after it was approved by the European Union.
 
The vaccine Dengvaxia was developed by the French pharmaceutical company Sanofi Pasteur.
 
It may now be sold in some European overseas territories with a tropical climate, including La Reunion whose population has been badly hit by the mosquito-borne disease.
 
The use of Dengvaxia is restricted to people between the ages of 9 and 45 who have had dengue before.
 
The vaccine is to prevent a second dengue infection which researchers say tends to be more serious.
 
Dengvaxia has earlier been approved in countries like Brazil and Mexico while Sanofi expects a decision by the US by May.

SOURCE: RNZ PACIFIC/PACNEWS


News feature
There are no related media to this article.
Pacific Islands News Association
Who & What is PINA?
Membership
Member Countries
Media Freedom
Training
PINA Convention
Awards
Contact
Gallery
Forum
Events
Jobs
Classifieds
PACNEWS
Home
Regional
Feature
Business
Sports
Archives
Partners
Communications Initiative
International News Safety Institute (INSI)
UNDP PC
AusAID
NZAID
SPREP
ONOC
UNAIDS
Media Helping Media
Partners
PIFS
SPC
IFEX
UNESCO
AIBD
GFMD
SEAPA
WPFC
IFJ